Immunotherapy in Cancer its Recent Advances and Challenges

Immunotherapy represents a significant breakthrough in the battle against cancer, offering promising outcomes and potential for improved survival rates and quality of life for patients. While therapies such as immune checkpoint inhibitors, CAR-T cell therapy, Tumor-infiltratings Lymphocytes, monoclonal antibodies, cancer vaccines, and Adoptive Cell Transfer have shown effectiveness, they also come with limitations and challenges. Continued research is essential to address these obstacles and enhance the efficacy and safety of immunotherapy across a wider range of cancer types. With ongoing advancements and refinement, immunotherapy holds the potential to achieve long-term remission and even complete recovery for some patients, marking a transformative milestone in cancer treatment.